Eris Lifesciences acquires 51% stake in Swiss Parenterals

16 Feb 2024 Evaluate

Eris Lifesciences has completed acquisition of 51% equity stake in Swiss Parenterals. On February 13, 2024, the company had executed Share Purchase and Shareholders’ agreement for acquisition of 51% equity stake in Swiss Parenterals. The cost of acquisition is Rs 637.50 crore. 

Eris Lifesciences develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives.

Eris Lifesciences Share Price

1443.90 -7.25 (-0.50%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×